Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 156.25 | 71.09 | 164.00 | 119.75 | 1.3695 | 2.0379 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 156.25 | 71.09 | 119.00 | 119.75 | 0.9937 | 0.9834 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 156.25 | 71.09 | 34.00 | 119.75 | 0.2839 | -0.6249 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 57.00 | 119.75 | 0.4760 | -0.2545 | |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 121.00 | 119.75 | 1.0104 | 1.0278 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 156.25 | 71.09 | 121.00 | 119.75 | 1.0104 | 1.0278 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 156.25 | 71.09 | 83.00 | 119.75 | 0.6931 | 0.2286 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 105.00 | 119.75 | 0.8768 | 0.6794 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 156.25 | 71.09 | 59.00 | 119.75 | 0.4927 | -0.2195 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 156.25 | 71.09 | 116.00 | 119.75 | 0.9687 | 0.9172 |
| BT-20 | Erlotinib | 10 | uM | 9 | 156.25 | 71.09 | 52.00 | 119.75 | 0.4342 | -0.3401 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 156.25 | 71.09 | 82.00 | 119.75 | 0.6848 | 0.2090 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 156.25 | 71.09 | 69.00 | 119.75 | 0.5762 | -0.0389 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 156.25 | 71.09 | 153.00 | 119.75 | 1.2777 | 1.7700 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 156.25 | 71.09 | 136.00 | 119.75 | 1.1357 | 1.3686 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 156.25 | 71.09 | 170.00 | 119.75 | 1.4196 | 2.1865 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 156.25 | 71.09 | 38.00 | 119.75 | 0.3173 | -0.5651 |
| BT-20 | Linsitinib | 10 | uM | 9 | 156.25 | 71.09 | 63.00 | 119.75 | 0.5261 | -0.1484 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 124.00 | 119.75 | 1.0355 | 1.0949 | |
| BT-20 | Lapatinib | 1 | uM | 9 | 156.25 | 71.09 | 123.00 | 119.75 | 1.0271 | 1.0725 |
| BT-20 | Lapatinib | 10 | uM | 9 | 156.25 | 71.09 | 31.00 | 119.75 | 0.2589 | -0.6682 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 156.25 | 71.09 | 79.00 | 119.75 | 0.6597 | 0.1505 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 156.25 | 71.09 | 98.00 | 119.75 | 0.8184 | 0.5322 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 156.25 | 71.09 | 123.00 | 119.75 | 1.0271 | 1.0725 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 156.25 | 71.09 | 59.00 | 119.75 | 0.4927 | -0.2195 |